Protocols
1 protocol(s) meet the specified criteria
Drug: TARCEVA
Protocol No.TitleStatus
A081105-CIRBRandomized Double Blind Placebo Controlled Study of Erlotinib or Placebo In Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)Open